GENE ONLINE|News &
Opinion
Blog

Solid Tumor
M&A
Foundation Medicine Fortifies Growing Prominence in Liquid Biopsy Space by Acquiring Lexent Bio
2020-06-15
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
CAR-T Therapy – a Boon for Cancer Treatment?
2020-04-27
Korean Biotech, AbClon Enters Trials with New CAR-T Molecule against Ovarian Cancer
2020-04-23
Eisai Obtains Novel Anti-Cancer Molecules via PRISM BioLab Contract
2020-04-13
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
Weekly in Asia|Oct-2
2019-10-23
The ups and downs of Chi-Med’s Fruquintinib
2018-11-28
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top